NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019
Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) in Paris from April 4th till 7th, 2019 along with the Abiogen team.
